[The first impressions of the therapeutic effect of mequitazine (Primalan) in allergic patients].
The therapeutic efficacy of Mequitasin (Primalin) was studied in 31 allergic patients--26 patients with allergic rhinitis and 5 patients with skin rashes (4 patients with acute urticaria and 1 patients with atopic dermatitis). The patients were given 1 tablet Primalin twice daily in the course of 14 days. In the patients with allergic rhinitis the effect of the treatment was considered very good in 42.41% of the patients treated, good--in 50% and lack of effect--in 7.69% of the patients. In the patients with urticaria and atopic dermatitis the results were very good in 60%, good--in 20% and no effect in 20% of the patients treated. Side effects were found in 5 patients: in 3 patients--mild up to moderate drowsiness, in 1 patient--weakness and 1 patient--dryness in the nose.